Jason B. Pieper, DVM, MS, DACVD, talked about pyoderma, including ingredients and formulations, in his lecture at the 2025 ...

(Nasdaq: RVNC) ("Revance" together with Dermata "Companies") today announced the Companies have entered into a clinical trial collaboration agreement to evaluate the topical application of Xyngari ...